TVRD
NASDAQTvardi Therapeutics
$3.80
-1.20 (-24.00%)
Institutional
28.9%
Insider
34.64%
Retail/Other
36.4%
Shares Outstanding
9.4M
Top Institutional Holders
As of Jul 2026| Holder | Shares | % | Change |
|---|---|---|---|
| Slate Path Capital LP | 704K | 7.5% | - |
| Vanguard Group Inc | 425K | 4.5% | +0.0M |
| BlackRock Inc | 388K | 4.1% | -0.0M |
| Vanguard Capital Management, LLC | 345K | 3.7% | +0.3M |
| American Financial Group Inc | 224K | 2.4% | - |
| Geode Capital Management, LLC | 182K | 1.9% | +0.0M |
| Silvercrest Asset Management Group LLC | 101K | 1.1% | - |
| State Street Corp | 97K | 1.0% | -0.0M |
| Renaissance Technologies Corp | 92K | 1.0% | -0.0M |
| Morgan Stanley - Brokerage Accounts | 73K | 0.8% | -0.0M |
Insider Transactions
Last 24 months (1 insiders)
Shaheen Wirk
Director
263,164 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 4,191 | - | $20,368* | 2025-04-15 | 4,191 |
Congressional Trading
STOCK Act DisclosuresNo congressional trading data available for this ticker.
Congressional trading data is sourced from STOCK Act disclosures and may not be available for all tickers.
Based on public disclosures. Reporting errors by representatives are common. Disclosure deadlines are 45 days after transaction.